Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Nuclear factor-B
100%
Vascular Function
100%
SP-1
100%
Cyclooxygenase-2
100%
PARP Inhibitor (PARPi)
100%
Diabetic Mice
44%
Vascular Dysfunction
33%
Phosphorylation
22%
Myogenic Tone
22%
Db Mouse
22%
Endothelium-dependent Relaxation
22%
MRNA Level
11%
Diabetes
11%
Lentivirus
11%
Blood Glucose
11%
Short Hairpin RNA (shRNA)
11%
Cyclooxygenase-2 Expression
11%
Endothelial Nitric Oxide Synthase (eNOS)
11%
Potentiation
11%
Type 2 Diabetic
11%
Double Knockout Mice
11%
Pressure-induced
11%
Dehydroxymethylepoxyquinomicin (DHMEQ)
11%
NBD Peptide
11%
Mesenteric Resistance Arteries
11%
Coronary Arterioles
11%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Cyclooxygenase 2
100%
Nuclear Factor
100%
Alternative Complement Pathway C3 C5 Convertase
100%
In Vitro
11%
Diabetes Mellitus
11%
Diabetes
11%
Downregulation
11%
Short Hairpin RNA
11%
Body Weight
11%
Arteriole
11%
Blood Glucose
11%
Artery Resistance
11%
Lentivirus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclooxygenase 2
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Nuclear Factor
100%
Db/Db Mouse
22%
Diabetes Mellitus
11%
Knockout Mouse
11%
Short Hairpin RNA
11%
Dehydroxymethylepoxyquinomicin
11%
Immunology and Microbiology
Complement Factor B
100%
Cyclooxygenase
100%
Artery
22%
Knockout Mouse
11%
Body Weight
11%
Lentivirus
11%
Downregulation
11%
Arteriole
11%
Glucose Blood Level
11%
Peptides
11%